CN102379989A - Traditional Chinese medicine for treating chronic hepatitis - Google Patents

Traditional Chinese medicine for treating chronic hepatitis Download PDF

Info

Publication number
CN102379989A
CN102379989A CN2011102313825A CN201110231382A CN102379989A CN 102379989 A CN102379989 A CN 102379989A CN 2011102313825 A CN2011102313825 A CN 2011102313825A CN 201110231382 A CN201110231382 A CN 201110231382A CN 102379989 A CN102379989 A CN 102379989A
Authority
CN
China
Prior art keywords
chinese medicine
chronic hepatitis
parts
traditional chinese
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011102313825A
Other languages
Chinese (zh)
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lvyuan Qiuzheng Technology Development Co Ltd
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2011102313825A priority Critical patent/CN102379989A/en
Publication of CN102379989A publication Critical patent/CN102379989A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a traditional Chinese medicine for treating chronic hepatitis, which belongs to the field of the traditional Chinese medicines for treating digestive system diseases and has the purposes of good effect and quick action. The traditional Chinese medicine for treating the chronic hepatitis is made of raw materials of dyers woad leaf, bighead atractylodes rhizome, glossy ganoderma, panax pseudo-ginseng, radix salviae miltiorrhizae, polyporus umbellatus, pericarpium citri reticulatae viride and the like. The traditional Chinese medicine for treating the chronic hepatitis has the functions of supporting the healthy energy, replenishing qi and nourishing the blood, clearing away heat and toxic material, activating blood circulation to dissipate blood stasis, and alleviating pain, and has the advantages of obvious effect, definite drug effect and quicker action.

Description

A kind of Chinese medicine of treating chronic hepatitis
Technical field
The invention belongs to the field of Chinese medicines of treatment digestive system disease.
Background technology
The present field of Chinese medicines that is intended to treat chronic hepatitis, the deficiency of two aspects of existence: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.So that large quantities of chronic hepatitis patients are because of can not get the treatment of active drug; Liver disease constantly develops, and clinical symptoms can not get alleviating, and the patient is seriously weak for a long time, dull pain in liver, liver function decline, hepatic fibrosis etc.; Life quality descends greatly, and I and family members are dissatisfied to this.
To problem set forth above, the present invention provides a kind of Chinese medicine of treating chronic hepatitis, and it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect; The slower problem that takes effect, effective, instant effect, it is remarkable to have effect; Drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention realizes through following technical scheme:
1, a kind of Chinese medicine of treating chronic hepatitis adopts the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Folium Isatidis 4---18 parts of 12 parts of Rhizoma Atractylodis Macrocephalaes 3---9 portions of Ganodermas 6---
Radix Notoginseng 1---9 parts of 3 parts of Radix Salviae Miltiorrhizaes 6---18 portions of Polyporus 3---
Pericarpium Citri Reticulatae Viride 3---9 parts
The Chinese medicine of this treatment chronic hepatitis is processed by following method:
(1) by above-mentioned weight ratio, Ganoderma is extracted ganoderan with decoction and alcohol sedimentation technique, technological process is following: Ganoderma is broken into graininess, crosses 40 mesh sieves Hot water (95 ℃) lixiviate with 1:20 Lixiviating solution decompression, concentrated 95% ethanol with 3 times of volumes mixes, left standstill 10-12 hours, centrifugal Add 75% ethanol, the deposition polysaccharide Dry the ganoderan extract fine powder;
(2) by above-mentioned weight ratio, Folium Isatidis, the Rhizoma Atractylodis Macrocephalae, Radix Salviae Miltiorrhizae, Polyporus, Pericarpium Citri Reticulatae Viride are extracted through conventional water extraction process, process extractum, oven dry is pulverized, and gets the extract fine powder;
(3) by above-mentioned weight ratio, Radix Notoginseng is ground into fine powder, mixes, stir, process Chinese medicine granules, capsule, tablet with above-mentioned (1), (2) two kinds of extract fine powders.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.We think that the main diseases of chronic hepatitis B is because of being the heresy of epidemic disease poison at research, and promptly patient's hypoimmunity causes viral infection, outbreak inflammation, state of an illness delay, obstinate.Though under present technical conditions, still can't virus be driven away fully externally, remove totally, we can suppress it through enhancing human body immunity power, and the control virus replication reduces viral load, and this is the key of treatment primary disease.So we attach most importance to Fuzheng Jiedu, benefiting QI and nourishing blood, blood circulation promoting and blood stasis dispelling is taken good care of the liver spleen, Qinghua hot and humid ecchymosis.The maximum value of the present invention just is: it has captured difficult two " difficult problems " that heal of delay in the chronic hepatitis treatment---and the one, " dull pain in liver " that is difficult to overcome significantly alleviated even disappeared, and the 2nd, insoluble " hepatic fibrosis reverse " realizes basically or fully.This is that doctor and patient call expectation hope for many years again and again.Ganoderma, Rhizoma Atractylodis Macrocephalae the body resistance strengthening and constitution consolidating among the we, benefiting QI and nourishing blood, the pivotal role of outstanding immunity, the easing the affected liver nourishing the liver, the spleen invigorating activating the spleen, enhancing human body immunity power, " opposing " interaction energy of immunity effectively resists hepatitis B virus duplicating in vivo, reduces its quantity; Radix Salviae Miltiorrhizae, Radix Notoginseng passage, nourishing blood, promoting blood circulation, removing blood stasis and relieving pain is enriched blood with nourishing the liver and kidney, removes the stagnant heat of blood part, and " reparation " effect of immunity can be repaired impaired hepatic tissue and liver function; Be aided with the soothing the liver dispelling the stagnated QI of Pericarpium Citri Reticulatae Viride, rush down pain relieving clearly, to separate dull pain in liver; The Folium Isatidis heat-clearing and toxic substances removing, the ability of holding concurrently removing heat from blood, the kind carbuncle sore redness of controlling; The Polyporus promoting diuresis to eliminate damp pathogen, the diuretic hepatoprotective, the kind wet edema, the dysuria that hold of stopping of harnessing the river, modern pharmacological research, polyporusum bellatus have the hepatitis virus resisting effect.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and heat-clearing and toxic substances removing, the merit of promoting blood circulation, removing blood stasis and relieving pain, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
Through following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
The Folium Isatidis 400 gram Rhizoma Atractylodis Macrocephalaes 300 kairine sesames 600 grams
Radix Notoginseng 100 gram Radix Salviae Miltiorrhizaes 600 gram Polyporus 300 grams
Pericarpium Citri Reticulatae Viride 300 grams
Press predetermined weight, Ganoderma is extracted with decoction and alcohol sedimentation technique; With conventional water extraction process Folium Isatidis, the Rhizoma Atractylodis Macrocephalae, Radix Salviae Miltiorrhizae, Polyporus, Pericarpium Citri Reticulatae Viride are extracted, process extract fine powder 250 grams altogether, Radix Notoginseng is ground into fine powder; Mix with said extracted thing fine powder; Stir, process fine particle, the capsule of packing into No. 0; Process 1166 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
2, get following prescription (weight in grams is a unit):
The Folium Isatidis 800 gram Rhizoma Atractylodis Macrocephalaes 600 kairine sesames 1100 grams
Radix Notoginseng 180 gram Radix Salviae Miltiorrhizaes 1100 gram Polyporus 600 grams
Pericarpium Citri Reticulatae Viride 600 grams
By above-mentioned same method, process 2200 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
3, get following prescription (weight is unit by gram):
The Folium Isatidis 1200 gram Rhizoma Atractylodis Macrocephalaes 900 kairine sesames 1800 grams
Radix Notoginseng 300 gram Radix Salviae Miltiorrhizaes 1800 gram Polyporus 900 grams
Pericarpium Citri Reticulatae Viride 900 grams
By above-mentioned same method, process 3500 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
4, get following prescription (by weight):
9 parts of 4 portions of Ganodermas of 5 parts of Rhizoma Atractylodis Macrocephalaes of Folium Isatidis
4 parts of 9 portions of Polyporus of 1 part of Radix Salviae Miltiorrhizae of Radix Notoginseng
4 parts on Pericarpium Citri Reticulatae Viride
By above-mentioned same method, process Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
5, get following prescription (by weight):
15 parts of 7 portions of Ganodermas of 10 parts of Rhizoma Atractylodis Macrocephalaes of Folium Isatidis
7 parts of 15 portions of Polyporus of 2 parts of Radix Salviae Miltiorrhizaes of Radix Notoginseng
7 parts on Pericarpium Citri Reticulatae Viride
By above-mentioned same method, process Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science chronic hepatitis, through 19 routine clinical observations.Selecting the tcm diagnosis chronic hepatitis is standard: limb is soft weak, and is weak from head to foot; Poor appetite, abdominal distention, dyspepsia; Face is pitch-dark, hepatic face is arranged; Dull pain in liver; Hepatic fibrosis is serious; It is undesired that liver function transaminase continues, and other index such as plasma albumin, blood STB etc. are unusual.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 11 examples, women's 8 examples do not have other serious disease, and the age is 47 years old-79 years old, 61.1 years old mean age.
Efficacy determination:
1, produce effects: weak alleviation, on one's body energetically; Poor appetite, abdominal distention, dull pain in liver are obviously alleviated, and the hepatic region is comfortable; Hepatic face is taken on a new look to some extent, and it is pale that face becomes; The hepatic fibrosis inspection is obviously alleviated; Indexs such as liver function test transaminase, plasma albumin are obviously improved.
2, effective: weak solution, on one's body energetically, abdominal distention, poor appetite, hepatic face are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking the Chinese medicinal capsule that the specific embodiment of the invention 2 is made, observed 6 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.3 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 6 months after, symptom is obviously improved.19 philtrums of clinical experiment, produce effects 9 people, effective 8 people, invalid 2 people, total effective rate 89.4%.

Claims (1)

1. Chinese medicine of treating chronic hepatitis is characterized in that: said Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Folium Isatidis 4---18 parts of 12 parts of Rhizoma Atractylodis Macrocephalaes 3---9 portions of Ganodermas 6---
Radix Notoginseng 1---9 parts of 3 parts of Radix Salviae Miltiorrhizaes 6---18 portions of Polyporus 3---
Pericarpium Citri Reticulatae Viride 3---9 parts
The Chinese medicine of this treatment chronic hepatitis is processed by following method:
(1) by above-mentioned weight ratio, Ganoderma is extracted ganoderan with decoction and alcohol sedimentation technique, technological process is following: Ganoderma is broken into graininess, crosses 40 mesh sieves Hot water (95 ℃) lixiviate with 1:20 Lixiviating solution decompression, concentrated 95% ethanol with 3 times of volumes mixes, left standstill 10-12 hours, centrifugal Add 75% ethanol, the deposition polysaccharide Dry the ganoderan extract fine powder;
(2) by above-mentioned weight ratio, Folium Isatidis, the Rhizoma Atractylodis Macrocephalae, Radix Salviae Miltiorrhizae, Polyporus, Pericarpium Citri Reticulatae Viride are extracted through conventional water extraction process, process extractum, oven dry is pulverized, and gets the extract fine powder;
(3) by above-mentioned weight ratio, Radix Notoginseng is ground into fine powder, mixes, stir, process Chinese medicine granules, capsule, tablet with above-mentioned (1), (2) two kinds of extract fine powders.
CN2011102313825A 2011-08-14 2011-08-14 Traditional Chinese medicine for treating chronic hepatitis Pending CN102379989A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011102313825A CN102379989A (en) 2011-08-14 2011-08-14 Traditional Chinese medicine for treating chronic hepatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011102313825A CN102379989A (en) 2011-08-14 2011-08-14 Traditional Chinese medicine for treating chronic hepatitis

Publications (1)

Publication Number Publication Date
CN102379989A true CN102379989A (en) 2012-03-21

Family

ID=45820089

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011102313825A Pending CN102379989A (en) 2011-08-14 2011-08-14 Traditional Chinese medicine for treating chronic hepatitis

Country Status (1)

Country Link
CN (1) CN102379989A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102626457A (en) * 2012-04-20 2012-08-08 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating chronic hepatitis
CN102626445A (en) * 2012-04-20 2012-08-08 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating cirrhosis
CN102631445A (en) * 2012-04-04 2012-08-15 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine (TCM) for treating chronic hepatitis
CN102670795A (en) * 2012-05-11 2012-09-19 北京绿源求证科技发展有限责任公司 Chinese medicine for treating chronic hepatitis
CN114832009A (en) * 2022-05-06 2022-08-02 安徽医科大学 Application of pennywort glycoside in medicine for treating hepatic fibrosis

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101953924A (en) * 2010-10-14 2011-01-26 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating chronic hepatitis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101953924A (en) * 2010-10-14 2011-01-26 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating chronic hepatitis

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102631445A (en) * 2012-04-04 2012-08-15 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine (TCM) for treating chronic hepatitis
CN102626457A (en) * 2012-04-20 2012-08-08 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating chronic hepatitis
CN102626445A (en) * 2012-04-20 2012-08-08 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating cirrhosis
CN102670795A (en) * 2012-05-11 2012-09-19 北京绿源求证科技发展有限责任公司 Chinese medicine for treating chronic hepatitis
CN114832009A (en) * 2022-05-06 2022-08-02 安徽医科大学 Application of pennywort glycoside in medicine for treating hepatic fibrosis

Similar Documents

Publication Publication Date Title
CN102379989A (en) Traditional Chinese medicine for treating chronic hepatitis
CN102389480A (en) Chinese medicament for treating hepatitis
CN102327358A (en) Traditional Chinese medicine for treating chronic hepatitis
CN102379947A (en) Traditional Chinese medicine for treating chronic hepatitis
CN102114074A (en) Traditional Chinese medicine for treating diabetic diarrhea
CN102138969A (en) Traditional Chinese medicine for treating diabetic diarrhea
CN101953924A (en) Traditional Chinese medicine for treating chronic hepatitis
CN102139049A (en) Traditional Chinese medicine for treating diabetic skin pruritus
CN101961386A (en) Traditional Chinese medicine for treating diabetic skin pruritus
CN102389479A (en) Traditional Chinese medicine for treating chronic hepatitis
CN101983683A (en) Traditional Chinese medicine for treating diabetic pruritus
CN102172375A (en) Traditional Chinese medicine for treating chronic hepatitis
CN101953925A (en) Traditional Chinese medicine for treating chronic hepatitis
CN102091165A (en) Traditional Chinese medicine for treating chronic hepatitis
CN101991685A (en) Traditional Chinese medicine for treating chronic hepatitis
CN102379994A (en) Traditional Chinese medicine for treating chronic hepatitis
CN102068533A (en) Traditional Chinese medicine for treating chronic hepatitis
CN101979023A (en) Chinese medicine for curing chronic hepatitis
CN101961420A (en) Traditional Chinese medicine for treating diabetic nephropathy
CN102048873A (en) Traditional Chinese medicine for treating chronic hepatitis
CN102389542A (en) Traditional Chinese medicine for treating chronic hepatitis
CN102138995A (en) Traditional Chinese medicine for treating chronic hepatitis
CN101979006A (en) Chinese medicament for treating chronic hepatitis
CN101972330A (en) Traditional Chinese medicine for treating chronic hepatitis
CN102091176A (en) Traditional Chinese medicine for treating diabetic diarrhoea

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120321